about
The use of molecular analyses in voided urine for the assessment of patients with hematuria.A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis.DNA methylation-based biomarkers in bladder cancer.Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.DNA methylation based biomarkers in colorectal cancer: A systematic review.Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancerHigh mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.Relationship between genome and epigenome--challenges and requirements for future researchGALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer.Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.A microRNA Signature Associated With Metastasis of T1 Colorectal Tumors to Lymph Nodes.A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine.Genome-wide discovery and identification of a novel miRNA signature for recurrence prediction in stage II and III colorectal cancer.Hypermethylation of the polycomb group target gene PCDH7 in bladder tumors from patients of all ages.A Novel Mirna-Based, Non-Invasive, Diagnostic Panel for Detection of Esophageal Squamous Cell CarcinomaGenome-Wide Analysis Revealed a Robust Gene Expression Signature to Identify Lymph Node Metastasis in Submucosal Colorectal CancerAbstract 5273: Role of methylation of Wnt target genes in tumorigenesis and effect of re-expression with demethylating agent decitabine in colon cancerStratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancerAbstract 4023: Genome-wide analysis of CpG island methylation identified OTX1, OSR1 and ONECUT2 as biomarkers for recurrent bladder cancer detection in voided urineAbstract 4897: Genome-wide analysis of CGIs in bladder cancer identifies novel epigenetic biomarkers for diagnosis and follow-upGene Expression Signature in Surgical Tissues and Endoscopic Biopsies Identifies High-risk T1 Colorectal CancersRNAMethyPro: a biologically conserved signature of N6-methyladenosine regulators for predicting survival at pan-cancer levelMolecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunitiesA comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinomaA 15-gene immune, stromal and proliferation gene signature that significantly associates with poor survival in patients with pancreatic ductal adenocarcinomaIntratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
P50
Q35021819-C3265F5B-3628-4692-A136-EE68F24EEF70Q37424650-163F0699-3694-4F1A-AD04-1562FB618393Q37688023-F17D8870-0D44-414A-80BC-0BD4650E7DFDQ38102879-547CD347-D1B6-4632-B916-18DD6BBB3999Q38328215-7F3EC942-AC06-4F09-B723-485ACB0C9F15Q38775209-10FF1435-F968-4B5F-A672-A3B151659C36Q38844637-FFF675B3-2E07-48EF-ACD8-5F1DF5FDD304Q41080927-5D6A0EDC-557A-4A7F-8F39-F550136AE1DBQ42366278-1C4EF458-E7FE-435C-8CD8-A0D2E1A40ACFQ42712507-3647CFAE-5781-480E-8E83-A332BE4E6D9AQ44398514-158A065A-3108-41AD-8CD2-041EFEFC6653Q47203432-66FF7552-97EA-4DF1-A5E6-9A59869509F4Q47377596-B3BAF6C4-34FB-48D0-9666-1E5B81EAEE8DQ48032053-12FC85AB-D60A-4D61-9F06-9E718C36DF70Q52668716-70C25F8E-09E5-4A87-89C3-9F3FC5860274Q53258787-A94DAADF-0A5D-42B7-AD23-E96F97BF23B6Q58862316-1DB54C5E-3674-4C71-8543-E753777AEB62Q58862319-F7688BC4-60C0-4485-A9BC-E17CB9273391Q58862323-3D463E0D-42D1-4675-856E-F88C1F03DE39Q58862326-514EF3EC-4A80-4678-9D4D-FA75F2D7EDBAQ58862329-7409951A-7D88-4313-8AC3-EAD3284A0132Q58862331-8A926077-DF0E-4DCD-81F4-03F9F0C2CFDFQ62771969-CF26F41E-4312-4B55-8524-CA47D485C618Q64076452-B47110E1-1366-4E76-884D-C4AA705EFD45Q88727587-219E639D-D441-4F37-A7BA-0294B567771AQ90157754-F235D35E-C085-4B8D-B133-3BBC3CB1138EQ90802219-2591A1C6-4ACD-415C-9609-62AD7D5BC08DQ92264245-55D95134-E2A5-4A30-8F09-AFCF37D035EF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Raju Kandimalla
@ast
Raju Kandimalla
@en
Raju Kandimalla
@es
Raju Kandimalla
@nl
type
label
Raju Kandimalla
@ast
Raju Kandimalla
@en
Raju Kandimalla
@es
Raju Kandimalla
@nl
prefLabel
Raju Kandimalla
@ast
Raju Kandimalla
@en
Raju Kandimalla
@es
Raju Kandimalla
@nl
P1053
C-1400-2016
P106
P21
P31
P3829
P496
0000-0002-0342-5229